Vascular endothelial growth factor A

Results: 127



#Item
1Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro

Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro

Add to Reading List

Source URL: www.eumbrella.org

Language: English - Date: 2016-02-26 09:44:29
    2Co-Targeting of Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF) with Programmed Death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. Minu K. Srivastava, Chr

    Co-Targeting of Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF) with Programmed Death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. Minu K. Srivastava, Chr

    Add to Reading List

    Source URL: posters.omed.s3.amazonaws.com

    - Date: 2015-11-04 13:26:51
      3APPLI CATI O N N O T E Exploring gene promoters for experimentally-proven and putative transcription factor binding sites with TRANSFAC® Professional and the included Match™ tool TRANSFAC® Professional is a unique k

      APPLI CATI O N N O T E Exploring gene promoters for experimentally-proven and putative transcription factor binding sites with TRANSFAC® Professional and the included Match™ tool TRANSFAC® Professional is a unique k

      Add to Reading List

      Source URL: www.gene-regulation.com

      Language: English - Date: 2012-06-08 10:54:19
      4crossmark THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 290, NO. 36, pp–22224, September 4, 2015 © 2015 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A. Interleukin-1 Rece

      crossmark THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 290, NO. 36, pp–22224, September 4, 2015 © 2015 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A. Interleukin-1 Rece

      Add to Reading List

      Source URL: www.ibms.sinica.edu.tw

      Language: English - Date: 2015-12-15 21:41:00
      5Staphyloccocus aureus Cas9 an alternative Cas9 for genome editing applications A.E. Friedland, S. Shen, P. Singhal, A. Sousa, M. Collins, M.L. Maeder, G.G. Welstead, H. Jayaram, D. Bumcrot Editas Medicine, Cambridge, MA

      Staphyloccocus aureus Cas9 an alternative Cas9 for genome editing applications A.E. Friedland, S. Shen, P. Singhal, A. Sousa, M. Collins, M.L. Maeder, G.G. Welstead, H. Jayaram, D. Bumcrot Editas Medicine, Cambridge, MA

      Add to Reading List

      Source URL: www.editasmedicine.com

      Language: English - Date: 2016-08-17 16:20:25
      6Axl is essential for VEGF-A-dependent activation of PI3K/Akt

      Axl is essential for VEGF-A-dependent activation of PI3K/Akt

      Add to Reading List

      Source URL: emboj.embopress.org

      Language: English - Date: 2014-03-21 05:20:18
      7Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice

      Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice

      Add to Reading List

      Source URL: www.cardiab.com

      Language: English
      8Article pubs.acs.org/jmc Synthesis and Biological Evaluation of a Unique Heparin Mimetic Hexasaccharide for Structure−Activity Relationship Studies Sucharita Roy,† Ahmed El Hadri,‡,§ Sebastien Richard,‡ Fanny De

      Article pubs.acs.org/jmc Synthesis and Biological Evaluation of a Unique Heparin Mimetic Hexasaccharide for Structure−Activity Relationship Studies Sucharita Roy,† Ahmed El Hadri,‡,§ Sebastien Richard,‡ Fanny De

      Add to Reading List

      Source URL: www.momentapharma.com

      Language: English - Date: 2014-10-07 17:00:09
      9Kala Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2015 Annual Meeting WALTHAM, Mass., May 1, 2015 – Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic prod

      Kala Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2015 Annual Meeting WALTHAM, Mass., May 1, 2015 – Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic prod

      Add to Reading List

      Source URL: kalarx.com

      Language: English - Date: 2015-05-11 17:04:35
      10This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and shar

      This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and shar

      Add to Reading List

      Source URL: en.actc-lab.chem.uoa.gr

      Language: English - Date: 2012-03-25 13:29:56